Pfizer Halts COVID Shot Trial Because They Can’t Find Enough Test Subjects Willing to Take Another Booster Shot




Those seeking their 6th booster are now either dead, disabled or have finally woken up to reality.

by Nicolas Hulscher, MPH

Pfizer and BioNTech have halted a large U.S. clinical trial for their updated COVID-19 booster injection because they could not find enough participants willing to take another mRNA shot.

The study, targeting healthy adults aged 50–64, required tens of thousands of participants. Despite this, enrollment failed, confirming that public demand for COVID boosters has completely collapsed.

Those seeking their 6th booster are now either dead, disabled or have finally woken up to reality.

A recent Rasmussen survey found that 56% of Americans believe the COVID-19 vaccines have caused large numbers of deaths.

At the same time, real-world uptake has collapsed—only about 18% of Americans received a booster during the 2025–2026 season.

The era of mass booster compliance is over.


Nicolas Hulscher, MPH

Epidemiologist and Foundation Administrator, McCullough Foundation

Advertisement

read more…

Who Really Benefits From the CIA Chief’s Secretive Moscow Trip?

Rachel Marsden questions whether Baltic defence spending offers another motive

Bessent vs Wall Street: They Don't Understand This Economy

WORLD NEWS RT - September 5 2026 (17:00 MSK)

NZ 6th SEP 2026

Zelensky’s Drone Warning Sparks Russian Claims of Threat to Civil Aviation

Russian experts dispute whether aircraft or aviation networks are the target

Trump Says Europe Should Repay Billions America Spent Arming Ukraine

US president wants Europe billed for Biden-era weapons supplied to Kiev

share article

or copy this link: